Aurobindo Pharma Limited has informed the Exchange about Schedule of meet at BofA 2026 India Conference in Mumbai
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has disclosed that company officials will participate in the BofA 2026 India Conference in Mumbai on June 2, 2026, from 9:00 AM to 6:00 PM IST. The meeting will be held in-person and include group meetings with investors. The company has explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be discussed during the interactions. The schedule may be subject to change due to exigencies on either party's end.
This is a routine investor relations activity with no immediate impact on the stock. The explicit no-UPSI statement helps prevent any regulatory concerns. Such meetings are standard practice for maintaining investor relations.